Millibar (Indapamide Hemihydrate)

Indapamide, the active ingredient in Millibar, is a thiazide-like diuretic presented as an oral tablet for oral use. It treats hypertension and edema in adult patients. GNH USA supplies Millibar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal tubular system to manage fluid balance and blood pressure, making it useful in several cardiovascular conditions. Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. Edema: promotes diuresis to decrease excess fluid accumulation in peripheral tissues. Congestive heart failure: assists in fluid removal to improve symptoms of volume overload.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte disturbances such as low potassium - Fatigue or weakness - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Allergic reactions including rash or angioedema - Acute renal impairment - Blood dyscrasias such as leukopenia - Pancreatitis - Severe hypotension leading to syncope

Before initiating therapy, clinicians should consider several safety measures. - Monitor blood pressure regularly: ensure target levels are achieved without excessive drops. - Check serum electrolytes: especially potassium and sodium, before and during treatment. - Assess renal function: adjust use in patients with impaired kidney function. - Avoid abrupt discontinuation: taper if long‑term therapy is stopped. - Use cautiously in diabetic patients: monitor glucose as diuresis may affect control. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity due to reduced renal clearance. - NSAIDs (e.g., ibuprofen): may blunt diuretic effect and worsen renal function. - Corticosteroids: increase risk of hypokalemia and other electrolyte disturbances.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential for additive blood‑pressure lowering and hyperkalemia. - Antidiabetic agents: diuresis may enhance glucose lowering, requiring dose adjustment. - Beta‑blockers: combined antihypertensive effect may cause excessive blood‑pressure reduction.